Search by Drug Name or NDC
NDC 00168-0007-30 Nystatin 100000 [USP'U]/g Details
Nystatin 100000 [USP'U]/g
Nystatin is a TOPICAL OINTMENT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by E. Fougera & Co. a division of Fougera Pharmaceuticals Inc.. The primary component is NYSTATIN.
MedlinePlus Drug Summary
Topical nystatin is used to treat fungal infections of the skin. Nystatin is in a class of antifungal medications called polyenes. It works by stopping the growth of fungi that cause infection.
Related Packages: 00168-0007-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Nystatin Topical
Product Information
NDC | 00168-0007 |
---|---|
Product ID | 0168-0007_2563e491-2277-4393-8632-8127fb983e1d |
Associated GPIs | 90150080004215 |
GCN Sequence Number | 007283 |
GCN Sequence Number Description | nystatin OINT. (G) 100000/G TOPICAL |
HIC3 | Q5F |
HIC3 Description | TOPICAL ANTIFUNGALS |
GCN | 30150 |
HICL Sequence Number | 004129 |
HICL Sequence Number Description | NYSTATIN |
Brand/Generic | Generic |
Proprietary Name | Nystatin |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | nystatin |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | OINTMENT |
Route | TOPICAL |
Active Ingredient Strength | 100000 |
Active Ingredient Units | [USP'U]/g |
Substance Name | NYSTATIN |
Labeler Name | E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. |
Pharmaceutical Class | Polyene Antifungal [EPC], Polyenes [CS] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA062124 |
Listing Certified Through | 2024-12-31 |
Package
Package Images


NDC 00168-0007-30 (00168000730)
NDC Package Code | 0168-0007-30 |
---|---|
Billing NDC | 00168000730 |
Package | 30 g in 1 TUBE (0168-0007-30) |
Marketing Start Date | 1982-09-23 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 0.25853 |
Pricing Unit | GM |
Effective Date | 2024-02-21 |
NDC Description | NYSTATIN 100,000 UNIT/GM OINT |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1, 5 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
Standard Product Labeling (SPL)/Prescribing Information SPL 01777cce-37ea-499c-ab13-82041a37ccfc Details
DESCRIPTION
CLINICAL PHARMACOLOGY
Nystatin is an antifungal antibiotic which is both fungistatic and fungicidal in vitro against a wide variety of yeasts and yeast-like fungi. It probably acts by binding to sterols in the cell membrane of the fungus with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin is a polyene antibiotic that is obtained from Streptomyces noursei, and is the first well tolerated antifungal antibiotic of dependable efficacy for the treatment of cutaneous, oral and intestinal infections caused by Candida [Monilia]albicans and other Candida species. It exhibits no appreciable activity against bacteria.
Nystatin provides specific therapy for all localized forms of candidiasis. Symptomatic relief is rapid, often occurring within 24 to 72 hours after the initiation of treatment. Cure is effected both clinically and mycologically in most cases of localized candidiasis.
INDICATIONS AND USAGE
CONTRAINDICATIONS
PRECAUTIONS
ADVERSE REACTIONS
DOSAGE AND ADMINISTRATION
Nystatin Ointment should be applied liberally to affected areas twice a day or as indicated until healing is complete. Nystatin cream is usually preferred to nystatin ointment in candidiasis involving intertriginous areas; very moist lesions, however, are best treated with nystatin topical powder.
This preparation does not stain skin or mucous membranes and provides a simple, convenient means of treatment.
HOW SUPPLIED
Nystatin Ointment (100,000 USP Nystatin Units per gram) is a yellow ointment available as follows:
NDC 0168-0007-15 15 gram tube
NDC 0168-0007-30 30 gram tube
Store at controlled room temperature 15°- 30°C (59°-86°F).
E. FOUGERA & CO.
A division of Fougera Pharmaceuticals Inc.
Melville, New York 11747
I20715H
R08/11
#21
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15 G CONTAINER
PACKAGE LABEL – PRINCIPAL DISPLAY PANEL – 15 G CARTON
INGREDIENTS AND APPEARANCE
NYSTATIN
nystatin ointment |
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
||||||||||||||||||||
|
Labeler - E. Fougera & Co. a division of Fougera Pharmaceuticals Inc. (043838424) |